So, this year, forget those fad diets—or worse, crash diets—that undermine your health. Instead, consider using WeightWatchers, which claimed the spot for the number one best diet for weight loss.

You deposit a lump sum or contribute monthly and acquire your very own slice of the world's starriest companies.

I found that so many people were making their own GLP-1s and taking smaller amounts than normally prescribed,” she said. “I ...

Novo Nordisk’s Ozempic and Wegovy continue to outpace Eli Lilly’s Mounjaro and Zepbound, even though the latter are ...

From weight loss medications to frayed partnerships, these are the 10 most-read orthopedic stories that Becker's covered in 2024: ...

The proposed Biosecure Act as well as the diversification of American and European firms away from China are expected to help ...

On any given day, millions of people in the U.S. are trying to lose weight. Recent data from the Centers for Disease Control and Prevention reports that a little over 40% of adults in the U.S.

The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for health insurers and ...

Kristin Cavallari revealed she is back in a new man’s arms and is dating a retired athlete three months after her split from ...

Ozempic and the Olympics, Diddy and The Donald, royal courage and calamity, lawfare and a leftwing establishment left humiliated.

Stay updated on the latest developments in the GLP-1 drug class, including a new generic entering the market, weight loss results, FDA decisions & cost issues.

Following rapid (and pricey) expansion efforts from Novo and Lilly, plus recent shortage updates at the FDA, “positive ...